These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 15988811

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) for diagnosis of bone metastasis in patients with primary lung cancer].
    Yokoyama T, Yamamoto M, Shima K, Suzuki K, Sako C, Ito G, Kume M, Maeda M.
    Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):857-60. PubMed ID: 14727545
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of bone markers for detection of bone metastases in lung cancer patients.
    Alataş F, Alataş O, Metintaş M, Colak O, Erginel S, Harmanci E.
    Clin Biochem; 2002 Jun; 35(4):293-6. PubMed ID: 12135691
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.
    Tamiya M, Suzuki H, Kobayashi M, Sasada S, Okamoto N, Morishita N, Yasue T, Matsuura Y, Hirashima T, Kawase I.
    Med Oncol; 2012 Mar; 29(1):215-8. PubMed ID: 21258879
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results.
    Lumachi F, Marino F, Fanti G, Chiara GB, Basso SM.
    Anticancer Res; 2011 Nov; 31(11):3879-81. PubMed ID: 22110213
    [Abstract] [Full Text] [Related]

  • 13. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW, Pecherstorfer M, Li Y, Keck AV, Horn E, Ziegler R, Seibel MJ.
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [Abstract] [Full Text] [Related]

  • 14. Markers of bone metastases in breast and lung cancers.
    Bilgin E, Yasasever V, Soydinc HO, Yasasever CT, Ozturk N, Duranyildiz D.
    Asian Pac J Cancer Prev; 2012 May; 13(9):4331-4. PubMed ID: 23167338
    [Abstract] [Full Text] [Related]

  • 15. [Diagnostic value of urinary N-telopeptide of type I collagen in prostate cancer: comparison with bone scintigraphy].
    Fukumitsu N, Uchiyama M, Mori Y, Yanada S, Hatano T, Igarashi H, Nakada J.
    Kaku Igaku; 1999 May; 36(4):333-9. PubMed ID: 10390956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer.
    Takeuchi S, Arai K, Saitoh H, Yoshida K, Miura M.
    J Urol; 1996 Nov; 156(5):1691-5. PubMed ID: 8863572
    [Abstract] [Full Text] [Related]

  • 20. The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer.
    Bayrak SB, Ceylan E, Serter M, Karadağ F, Demir E, Çildağ O.
    Int J Clin Oncol; 2012 Apr; 17(2):112-8. PubMed ID: 21691728
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.